Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients

By M. Shlipak, P. Heidenreich, H. Noguchi, Glenn M. Chertow, W. Browner, M. Mcclellan. Annals of Internal Medicine, 2002

601 citations recorded by the source corpus.

Subfields: Nephrology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/04510db3ffe0b53268d1fae77de3561aede6fdfe

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Nephrology

1. A. Levey
2. Josef Coresh

Citations in the corpus

• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “In patients referred for CABG, short-acting intravenous GP IIb/IIIa inhibitors (eptifibatide or tirofiban) should be discontinued for at least 2 to 4 hours before surgery (236, 237) and abciximab for at least 12 hours before to limit blood loss and transfusion (238).”
• Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. (2004, background): “Furthermore, patients with kidney disease likely receive less aggressive therapy for risk-factor modification (7,8,37).”